Circular RNA expression profile of Alzheimer's disease and its clinical significance as biomarkers for the disease risk and progression

Int J Biochem Cell Biol. 2020 Jun:123:105747. doi: 10.1016/j.biocel.2020.105747. Epub 2020 Apr 19.

Abstract

Objective: To investigate circular RNA (circRNA) expression profile via microarray, and further assess the potential of candidate circRNAs as biomarkers in Alzheimer's disease (AD).

Methods: CircRNA expression profile in cerebrospinal fluid from 8 AD patients and 8 control (Ctrl) subjects was assessed by microarray. Subsequently, 10 candidate circRNAs from microarray were validated by reverse transcription quantitative polymerase chain reaction (RT-qPCR) in cerebrospinal fluid from 80 AD patients and 40 Ctrl subjects.

Results: By microarray, 112 circRNAs were upregulated and 51 circRNAs were downregulated in AD patients compared with Ctrl subjects, and these circRNAs were enriched in AD related pathways such as neurotrophin signaling pathway, natural killer cell mediated cytotoxicity and cholinergic synapse. By RT-qPCR, circ-LPAR1, circ-AXL and circ-GPHN were increased, whereas circ-PCCA, circ-HAUS4, circ-KIF18B and circ-TTC39C were decreased in AD patients compared with Ctrl subjects, and these circRNAs were disclosed to predict AD risk by receiver operating characteristics curve analysis. Further forward-stepwise multivariate logistic regression revealed that circ-AXL, circ-GPHN, circ-ITPR3, circ-PCCA and cic-TTC39C were independent predictive factors for AD risk. Besides, in AD patients, circ-AXL and circ-GPHN negatively correlated, while circ-PCCA and circ-HAUS4 positively correlated with mini-mental state examination score; Circ-AXL negatively correlated, while circ-PCCA, circ-HAUS4 and circ-KIF18B positively correlated with Aβ42; Circ-AXL and circ-GPHN positively correlated, whereas circ-HAUS4 negatively correlated with t-tau; Circ-AXL positively correlated with p-tau.

Conclusion: Our study provides an overview of circRNA expression profile in AD, and identifies that circ-AXL, circ-GPHN and circ-PCCA hold clinical implications for guiding disease management in AD patients.

Keywords: Alzheimer’s disease; circular RNA; clinical significance; expression profile; mini-mental state examination score; reverse transcription quantitative polymerase chain reaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / cerebrospinal fluid*
  • Alzheimer Disease / genetics
  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Amyloid beta-Peptides / genetics
  • Amyloid beta-Peptides / metabolism
  • Biomarkers / cerebrospinal fluid
  • Disease Progression
  • Down-Regulation
  • Female
  • Gene Ontology
  • Humans
  • Killer Cells, Natural / immunology
  • Logistic Models
  • Male
  • MicroRNAs / cerebrospinal fluid
  • MicroRNAs / genetics
  • Microarray Analysis
  • Middle Aged
  • Nerve Growth Factors / cerebrospinal fluid
  • Nerve Growth Factors / genetics
  • Non-Neuronal Cholinergic System / genetics
  • Peptide Fragments / cerebrospinal fluid*
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism
  • RNA, Circular / cerebrospinal fluid*
  • RNA, Circular / genetics
  • ROC Curve
  • Real-Time Polymerase Chain Reaction
  • Signal Transduction / genetics*
  • Up-Regulation
  • tau Proteins / cerebrospinal fluid*
  • tau Proteins / genetics
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • Biomarkers
  • MicroRNAs
  • Nerve Growth Factors
  • Peptide Fragments
  • RNA, Circular
  • amyloid beta-protein (1-42)
  • tau Proteins